introduc
new
class
invari
md
trajectori
base
spectral
moment
p
k
l
markov
matrix
associ
lattic
networklik
ln
graph
represent
molecular
dynam
md
trajectori
procedur
emb
md
energi
profil
cartesian
coordin
system
use
simpl
heurist
rule
time
associ
ln
markov
matrix
describ
probabl
pass
one
state
new
space
construct
type
ln
md
trajectori
obtain
dnadrug
dock
experi
furocoumarin
combin
use
psoralen
ultraviolet
light
uva
radiat
known
puva
therapi
puva
effect
treatment
skin
diseas
psoriasi
mycosi
fungoid
puva
also
use
treat
human
platelet
ptl
concentr
order
elimin
leishmania
spp
trypanosoma
cruzi
parasit
caus
leishmaniosi
danger
skin
viscer
diseas
chaga
diseas
respect
may
circul
blood
product
collect
infect
donor
includ
studi
lineal
psoralen
angular
angelicin
furocoumarin
studi
group
ln
two
set
dnadrug
complex
md
trajectori
activ
compound
md
trajectori
nonact
compound
nooptim
md
trajectori
activ
compound
calcul
respect
p
k
l
valu
ln
use
input
train
new
classifi
discrimin
case
train
seri
model
correctli
classifi
specif
sensit
trajectori
independ
valid
seri
model
correctli
classifi
specif
sensit
trajectori
propos
new
model
score
function
guid
dnadock
studi
drug
design
new
coumarin
anticanc
antiparasit
puva
therapi
quantit
structureact
relationship
qsar
studi
unravel
structur
physicochem
requir
biolog
activ
great
varieti
compound
classic
qsar
studi
connect
inform
chemic
structur
molecul
express
mean
number
biolog
activ
howev
qsarlik
procedur
restrict
drug
biolog
activ
system
properti
allergen
charact
protein
may
predict
one
special
class
indic
use
qsar
call
topolog
indic
ti
base
concept
molecular
graph
indic
presenc
vertic
node
atom
connect
edg
node
chemic
bond
way
field
applic
ti
cours
restrict
chemistri
lowmolecularweight
compound
extend
branch
scienc
gener
ti
differ
type
graph
represent
network
protein
structur
gene
polymorph
metabol
network
food
web
hostparasit
network
internet
social
network
may
use
network
amino
acid
nucleotid
enzym
microorgan
cerebr
cortex
region
web
page
social
groupsetc
may
play
role
node
electrostat
interact
mutat
metabol
reaction
hostparasit
relationship
brain
region
coactiv
link
diseas
propagationsetc
may
play
role
edg
instanc
pseudo
amino
acid
pseaa
composit
pseaac
method
calcul
protein
ti
origin
introduc
chou
improv
predict
qualiti
protein
subcellular
local
membran
protein
type
well
enzym
function
class
pseaa
composit
use
repres
protein
sequenc
discret
model
yet
without
complet
lose
sequenceord
inform
ever
sinc
concept
chou
pseudo
amino
acid
composit
introduc
variou
pseaac
approach
stimul
enhanc
predict
qualiti
variou
protein
featur
owe
wide
usag
recent
flexibl
pseudo
amino
acid
composit
gener
call
pseaac
establish
websit
http
choumedharvardedubioinfpseaac
user
gener
differ
kind
pseaa
composit
includ
dipeptid
compon
public
area
steadili
increas
consequ
last
year
appear
indepth
review
could
use
reader
present
manuscript
mani
author
prefer
use
term
quantit
structurebind
affin
relationship
qsbr
one
use
qsarlik
procedur
predict
drugtarget
bind
affin
structur
inform
anyhow
term
qsbr
use
care
avoid
confus
quantit
structurebiodegrad
relationship
analysi
work
use
qsbr
first
sens
case
approach
qsar
qsbr
diverg
degre
type
measur
activ
bind
sometim
detail
manner
need
know
chemic
structur
use
essenti
algorithm
addit
predict
drug
activ
use
drugtarget
qsarqsbr
model
score
function
guid
search
optim
drugtarget
interact
geometri
drugtarget
dock
studi
almost
qsarqsbr
type
dock
score
function
aim
predict
proteindrug
interact
instanc
wang
et
al
report
compar
studi
eleven
wherea
ferrara
et
al
studi
nine
differ
dock
score
function
proteindrug
interact
convers
dnadrug
rnadrug
dock
gener
less
investig
particular
find
qsbr
score
function
dnafurocoumarin
dock
furocoumarin
class
natur
synthet
compound
interest
pharmacolog
properti
commonli
use
treatment
skin
diseas
psoriasi
mycosi
fungoid
treatment
call
puva
consist
therapi
combin
use
chemic
longwav
ultraviolet
light
uva
molecular
basi
puva
connect
highli
specif
photodamag
dna
epiderm
cell
damag
interfer
dna
replic
produc
inhibit
dna
synthesi
reduc
block
cell
duplic
although
lineal
furocoumarin
psoralen
abl
form
three
adduct
type
geometri
angular
one
angelicin
allow
form
monoadduct
dna
well
known
side
effect
observ
puva
therapi
skin
phototox
risk
skin
cancer
strictli
connect
bifunct
lesion
dna
recent
eastman
et
al
demonstr
effect
puva
treatment
psoralen
analogu
call
amotosalen
inactiv
parasit
leishmania
spp
human
platelet
plt
concentr
intend
transfus
leishmania
spp
protozoan
caus
skin
viscer
diseas
leishmania
spp
oblig
intracellular
parasit
mononuclear
phagocyt
document
transmit
blood
transfus
metacyl
promastigot
amastigot
extrem
suscept
photochem
inactiv
puva
promastigot
repres
infecti
sand
fli
vector
amastigot
form
grow
mononuclear
phagocyt
thu
puva
plt
concentr
inactiv
form
leishmania
would
expect
circul
blood
product
collect
infect
donor
addit
gottlieb
et
al
report
inactiv
bloodborn
parasit
trypanosoma
cruzi
cruzi
puva
amt
plt
concentr
infect
parasit
elimin
jcm
trypomastigot
motil
continu
least
hposttreat
inhibit
much
higher
light
dose
isol
total
dna
parasit
cell
treatment
presenc
indic
lethal
uva
influenc
amt
adduct
per
kilobas
pair
occur
result
suggest
puva
methodolog
may
elimin
bloodborn
cruzi
caus
agent
chaga
diseas
recent
castro
giron
demonstr
pathogen
reduct
system
base
puva
amotosalen
present
robust
efficaci
inactiv
high
dose
three
differ
strain
cruzi
offer
potenti
make
plt
suppli
safer
biolog
activ
compound
normal
studi
evalu
capac
form
intercal
complex
dna
abil
photobind
mono
bifunct
addit
macromolecul
tradit
procedur
determin
photobiolog
antiprolif
activ
furocoumarin
measur
id
uva
dose
reduc
dna
synthesi
ehrlich
ascit
tumor
cell
eatc
presenc
test
compound
certain
concentr
mm
protocol
use
activ
determin
heterogen
howev
use
refer
express
activ
common
fact
point
stabil
dnadrug
complex
central
factor
activ
anticanc
drug
gener
includ
furocoumarin
light
fact
molecular
dynam
md
dnadrug
complex
central
drug
design
toward
puva
therapi
sinc
advent
bioscienc
studi
karplu
et
al
md
becom
foremost
wellestablish
comput
techniqu
investig
structur
function
biomolecul
respect
complex
interact
addit
pioneer
paper
entitl
biolog
function
lowfrequ
phonon
publish
seri
investig
biopolym
md
point
view
stimul
studi
suggest
lowfrequ
terahertz
frequenc
collect
motion
exist
protein
dna
hold
high
potenti
reveal
profound
dynam
mechan
mani
marvel
biolog
function
biolog
system
see
eg
comprehens
review
kind
infer
later
observ
nmr
use
medic
treatment
view
understand
realli
interact
mechan
drug
protein
dna
consid
static
structur
concern
also
dynam
inform
obtain
simul
interact
dynam
process
sens
high
relev
take
account
previou
noncoval
bind
dark
drug
dna
strong
influenc
subsequ
photoreact
therefor
biolog
activ
consequ
md
studi
dnadrug
complex
furocoumarin
anticanc
drug
gener
major
relev
sens
would
interest
work
invari
encod
inform
md
trajectori
intercal
complex
furocoumarin
anticanc
drug
gener
analysi
md
trajectori
result
integr
equat
motion
md
remain
howev
greatest
challeng
requir
great
deal
insight
experi
effort
recent
import
work
hamach
propos
new
theoret
sound
versatil
analysi
procedur
provid
scientist
semiquantit
invari
measur
compar
variou
scenario
respect
simul
howev
use
graphic
approach
studi
biolog
system
provid
use
insight
indic
mani
previou
studi
seri
import
biolog
topic
graph
use
studi
enzymecatalyz
reaction
protein
fold
kinet
inhibit
kinet
process
nucleic
acid
polymeras
nucleas
codon
usag
base
frequenc
antisens
strand
analysi
dna
sequenc
moreov
graphic
method
introduc
qsar
studi
well
util
deal
complic
network
system
recent
cellular
automaton
imag
also
appli
studi
hepat
b
viral
infect
hbv
viru
gene
misssens
mutat
visual
analysi
sarscov
well
repres
complic
biolog
sequenc
help
identifi
protein
attribut
sever
author
use
pseudofold
lattic
hydrophobicitypolar
hp
model
simul
protein
fold
make
simul
optim
lattic
structur
resembl
real
fold
howev
choos
notabl
simpler
pseudofold
rule
avoid
optim
procedur
speed
notabl
construct
lattic
sens
use
graph
represent
dna
rna
andor
protein
sequenc
introduc
nandi
et
al
gate
leong
morgenthal
randic
et
al
base
coordin
system
call
graph
represent
sequenc
pseudofold
lattic
network
ln
look
like
lattic
structur
fact
forc
sequenc
fold
way
necessarili
occur
natur
gener
ln
graph
numer
character
ti
ti
describ
distribut
amino
acid
nucleotid
along
sequenc
also
encod
higher
order
inform
thu
lattic
pseudofold
ti
use
protein
qsar
group
use
differ
marchinsid
ti
pseudofold
latticelik
network
predict
divers
protein
dnarna
function
instanc
use
stochast
pseudofold
spectral
moment
predict
ribonucleas
dynein
work
use
markov
chain
pseudofold
electrostat
potenti
predict
polygalacturonas
human
colon
breast
cancer
biomark
marchinsid
pseudofold
ti
calcul
sum
respect
indic
node
graph
abovement
valu
use
recent
predict
mycobacterium
promot
compar
entropi
spectral
moment
pseudofold
electrostat
potenti
reader
may
see
three
recent
review
discuss
applic
rang
graph
small
molecul
graph
network
represent
protein
sequenc
structur
dna
sequenc
rna
secondari
structur
human
blood
proteom
mass
spectroscopi
outcom
case
understand
sequenc
type
input
data
need
limit
applic
pseudofold
lattic
network
method
protein
dna
rna
sequenc
elabor
line
think
propos
pseudofold
lattic
network
represent
mass
spectroscopi
outcom
typic
blood
proteom
sampl
contain
mani
protein
instanc
construct
lattic
network
represent
mass
spectroscopi
result
obtain
blood
proteom
sampl
typic
drug
caus
cardiotox
calcul
sum
ti
sampl
use
seek
new
type
classifi
model
connect
ti
valu
mass
spectra
blood
proteom
probabl
appear
drug
cardiotox
new
type
model
call
quantit
proteomeproperti
relationship
qppr
analog
qsar
qspr
use
lattic
network
ti
also
predict
human
prostat
cancer
success
strategi
encourag
us
consid
class
sequenc
data
solv
differ
problem
instanc
md
trajectori
refer
previou
paragraph
time
seri
obtain
simul
run
constitut
anoth
type
sequenti
data
case
even
spectral
moment
differ
graph
success
use
qsar
see
spectral
moment
ln
md
trajectori
explor
consequ
decid
studi
indic
describ
md
trajectori
present
paper
introduc
ln
represent
studi
md
trajectori
also
obtain
quantit
model
abl
differenti
furocoumarin
deriv
accord
antiprolif
activ
stabil
dnadrug
complex
new
model
also
qsbr
potenti
applic
score
function
dnafurocoumarin
dock
studi
studi
use
decanucleotid
sequenc
ccgctagcgg
softwar
applic
hyperchem
fragment
dna
doubl
helix
b
form
sugar
endo
form
decanucleotid
sequenc
use
differ
studi
concern
psoralen
intercal
structur
compound
select
dnadrug
interact
studi
optim
use
interact
model
build
packag
hyperchem
optim
geometri
carri
semiempir
quantum
mechan
calcul
method
use
polakribier
algorithm
option
implement
default
mention
packag
thu
minim
molecular
structur
intercal
hand
approach
dna
fragment
use
hyperchem
packag
take
account
follow
experiment
demonstr
statement
dark
poli
dadt
poli
dadt
sequenc
dna
favor
site
intercal
sinc
photoreact
take
place
mainli
doubl
bond
thymin
optim
molecul
insert
among
thymin
unit
parallel
plane
base
accord
decis
halfway
posit
fig
left
furocoumarin
two
reactiv
site
photoreact
differ
type
cycloadduct
form
mono
furansid
pyronesid
diadduct
crosslink
although
psoralen
abl
form
cycloadduct
type
angelicin
form
monoadduct
owe
angular
molecular
structur
keep
mind
lineal
molecul
model
one
start
conform
cycloadduct
format
either
one
reactiv
site
furan
pyronesid
equal
feasibl
geometr
point
view
angular
molecul
decid
model
two
start
conform
one
monoadduct
format
furansid
name
jconform
pyronesid
name
cconform
stereochemistri
furocoumarin
adduct
cissyn
consequ
molecul
orient
way
intercal
complex
favor
mainli
format
cycloadduct
stereochemistri
case
furansid
stereochemistri
syn
mean
furan
pyrimidin
n
go
adjac
corner
futur
cyclobutan
ring
pyronesid
stereochemistri
syn
defin
carbonylcarbon
pyron
ring
n
pyrimidin
adjac
corner
futur
cyclobutan
ring
fig
right
hand
studi
angular
molecul
present
ramif
carbon
hinder
us
model
appropri
jconform
due
steric
problem
thymin
ring
also
found
steric
impedi
backbon
dna
ramif
much
bigger
case
decid
model
sever
altern
start
conform
steric
effect
elimin
major
case
vari
insert
degre
molecul
dna
critic
case
also
rotat
molecul
clockwis
see
fig
tabl
detail
displac
outward
dna
molecul
rotat
carri
halfway
parallel
plane
nitrogen
base
sens
geometr
criterion
use
rel
distanc
plane
project
geometr
center
doubl
bond
j
c
bond
furocoumarin
bond
thymin
take
part
photoaddit
rel
angl
tabl
fig
variat
geometr
paramet
use
model
jconform
repres
simplifi
way
take
aspect
consider
notat
md
trajectori
given
bonddistang
number
compound
tabl
tabl
bond
j
c
j
c
chemic
bond
suscept
photoaddit
posit
wherea
dist
ang
distanc
angular
intercal
paramet
respect
see
tabl
dnadrug
dock
molecular
dynam
trajectori
energet
profil
start
intercal
complex
obtain
mean
mont
carlo
method
use
hyperchem
packag
sens
forc
field
molecular
mechan
use
distantdepend
dielectr
constant
scale
factor
electrostat
van
der
waal
valu
default
cutoff
shift
outer
radiu
compon
forc
field
includ
atom
type
recalcul
keep
current
charg
final
simul
execut
vacuo
k
optim
step
obtain
md
trajectori
potenti
energi
e
j
j
valu
obtain
md
trajectori
psoralen
md
trajectori
differ
angelicin
also
analyz
averag
md
trajectori
angelicin
take
secondli
method
use
matrix
p
squar
matrix
character
md
profil
embed
latticelik
graph
pleas
note
number
node
n
graph
may
equal
even
smaller
number
step
given
obtain
md
profil
happen
amino
acid
dna
base
polymer
chain
accordingli
matrix
p
contain
probabl
p
ij
reach
node
n
move
throughout
walk
length
k
node
n
j
e
j
sum
energi
valu
step
e
overlap
node
j
paramet
ij
equal
node
n
n
j
adjac
graph
equal
otherwis
valu
give
geometr
locat
node
repres
euclidean
distanc
node
center
coordin
fig
bottom
part
depict
exampl
ln
md
trajectori
afterward
straightforward
realiz
calcul
p
k
l
valu
use
mcm
calcul
p
k
valu
associ
electron
distribut
molecul
drug
theoret
foundat
method
given
previou
work
detail
refer
reader
work
use
p
k
valu
addit
p
k
l
valu
describ
drug
md
trajectori
p
k
valu
spectral
moment
classic
electron
markov
matrix
p
valu
use
qsar
depend
connect
chemic
bond
node
atom
molecular
graph
electroneg
c
j
atom
valu
p
k
refer
atom
node
molecular
graph
vector
element
markov
chain
base
stochast
matrix
p
contain
element
describ
probabl
transit
electron
p
j
node
atom
ith
jth
order
ensur
p
j
valu
describ
probabl
transit
electron
node
atom
ith
jth
use
atmoic
electroneg
valu
follow
give
formula
transit
probabl
element
matrix
atom
set
entropi
central
measur
studi
select
differ
furocoumarin
azaanalogu
whose
antiprolif
activ
ehrlich
ascit
tumor
cell
determin
tabl
obtain
total
md
trajectori
compound
construct
ln
one
md
trajectori
transform
vector
p
k
valu
compound
p
k
l
valu
md
trajectori
see
previou
section
group
md
trajectori
two
set
one
compos
md
trajectori
complex
dna
activ
compound
compos
trajectori
activ
compound
nooptim
md
trajectori
andor
trajectori
nonact
compound
gener
compound
map
activ
id
rel
consid
poorli
activ
keep
mind
abovement
aspect
classifi
compound
compil
dataset
two
observ
activ
group
inact
compound
ld
activ
one
ld
qsbr
studi
carri
obtain
model
allow
us
classifi
furocoumarin
deriv
one
two
activ
group
select
linear
discrimin
analysi
lda
fit
discrimin
function
implement
lda
modul
statistica
softwar
packag
use
forwardstepwis
algorithm
variabl
select
strength
correl
determin
canon
regress
coeffici
rc
statist
signific
lda
model
determin
ustatist
u
respect
plevel
p
standard
variabl
includ
model
order
bring
scale
subsequ
standard
linear
discrimin
equat
allow
compar
coeffici
obtain
also
inspect
percentag
good
classif
casesvari
ratio
r
paramet
number
variabl
explor
avoid
overfit
chanc
correl
gener
form
model
comput
approach
structur
bioinformat
molecular
dock
mont
carlo
simul
anneal
approach
qsar
time
provid
output
model
mdscore
real
valu
variabl
score
predict
good
fit
one
md
trajectori
statist
predict
follow
three
crossvalid
method
often
use
examin
predictor
effect
practic
applic
independ
dataset
test
subsampl
test
jackknif
test
howev
elucid
demonstr
among
three
crossvalid
method
jackknif
test
deem
object
alway
yield
uniqu
result
given
benchmark
dataset
henc
increasingli
wide
use
investig
examin
accuraci
variou
predictor
see
eg
current
studi
jackknif
test
would
take
lot
comput
time
choos
use
independ
dataset
test
examin
predict
accuraci
model
train
train
seri
later
valid
extern
valid
seri
train
seri
model
correctli
classifi
specif
optim
sensit
nooptim
md
trajectori
extern
valid
seri
model
correctli
classifi
specif
optim
sensit
nooptim
md
trajectori
result
repres
total
accuraci
train
valid
respect
previou
qsar
work
use
lda
classif
techniqu
accept
level
sensit
specif
accuraci
indic
high
qualiti
model
obtain
new
type
graph
theoret
represent
molecular
dynam
md
trajectori
resembl
ln
use
dna
protein
sequenc
time
possibl
calcul
new
class
invari
md
trajectori
base
spectral
moment
p
k
l
markov
matrix
associ
ln
p
k
l
valu
use
input
train
new
classifi
order
discrimin
optim
nooptim
intercal
mode
relev
biolog
activ
new
model
use
score
function
guid
dnadock
studi
drug
design
new
coumarin
puva
therapi
